Stock AnalizColgate Palmolive Co. CL
Package Goods/Cosmetics · data as of November 13, 2026
Colgate Palmolive Co. (CL) is a consumer discretionary company listed in the US with a market value of about $79.2B. In the twelve months to September 30, 2026 it had revenue of $21.3B and net income of $2.1B, a net margin of 9.6%.
Its overall Stock Analiz score is 2.4 out of 5 (weak). The strongest part is shareholder returns (5/5); the weakest is value (0/5).
Key numbers: a P/E of 38.9, a price to free cash flow of 20.9, 5-year revenue growth of 4% a year, a 5-year average ROIC of 30%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 30% below the current price.
Score: 2.4 / 5
Checks passed
- 3-year free cash flow growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- ROE above 15%
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Pays a dividend
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.3B | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B |
| Net income | $2.1B | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B |
| Free cash flow | $3.8B | $3.6B | $3.5B | $3.0B | $1.9B | $2.8B | $3.3B | $2.8B | $2.6B | $2.5B | $2.5B |
| EPS (diluted) | $2.56 | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| Net margin | 9.6% | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| ROIC | — | 28.4% | 37.7% | 30.8% | 22.1% | 30.0% | 35.0% | 32.6% | 43.6% | 35.5% | 43.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 20 analysts is $101.70, 2% above the current price; targets range from $88.00 to $112.00; the consensus rating is “Buy”; expected EPS is $3.92 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Colgate Palmolive’s P/E ratio?
About 38.9, based on the last twelve months of diluted earnings per share (forward P/E about 24.9).
Is Colgate Palmolive stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 30% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Colgate Palmolive pay a dividend?
Yes. The dividend yield is about 2.16%, and it has paid dividends for 10 years in our data.
Is Colgate Palmolive a good stock to buy?
We do not give buy or sell advice. Colgate Palmolive scores 2.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.